Belgium· BE-AMP-SAM202343-00
Sonata 5 mg
A zaleplon product containing zaleplon, registered in Belgium by Meda. The same ATC class is registered in 5 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Zaleplon is registered in 5 of 19 countries.
Countries holding a registration under ATC N05CF03 (zaleplon), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 4 of them publish a price we can compare per daily dose
Zaleplon · ATC N05CF03
5 / 19 countries
- Belgiumprice
- Finlandprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Zaleplon
- Manufacturer
- Meda
- Country
- Belgium (BE)
- ATC code
- N05CF03
- ATC class
- Zaleplon
- Defined daily dose
- 10 mg, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb1442524
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
176 interactions on record for zaleplon.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Zaleplon · interactions on record
176 records
- 4 severe
- 72 moderate
- 7 minor
- 83 info
Most severe, free to view
- MorphineN02AA01severe
- MorphinN07BC09severe
- HydrocodoneR05DA03severe
- CodeineR05DA04severe
10 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Zaleplon in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StateszaleplonUnichem Pharmaceuticals (USA), Inc.
- United KingdomSonata 5mg capsulesMawdsley-Brooks & Company Ltd
- FinlandSonataMEDA AB
- PolandMorfeoAdamed Pharma S.A.
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Poland · Morfeo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fc82b7a2-da02-4640-ad92-2a6c317271ba GET /v1/drugs/fc82b7a2-da02-4640-ad92-2a6c317271ba?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Capsule, hard",
"source": "afmps",
"status": "REVOKED",
"name_en": "Sonata 5 mg",
"name_fr": "Sonata 5 mg",
"name_nl": "Sonata 5 mg",
"amp_code": "SAM202343-00",
"strengths": [
"5.0000"
],
"pack_count": 3,
"substances": [
"Zaleplon"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Zaleplon",
"authorisation_numbers": [
"EU/1/99/102/002",
"EU/1/99/102/003"
]
}See everything about zaleplon.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.